{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:17:55Z","timestamp":1790486275800,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11095-007-9495-x","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T15:13:19Z","timestamp":1195053199000},"page":"1037-1042","source":"Crossref","is-referenced-by-count":19,"title":["Thyroid Hormone Regulates the Expression and Function of P-glycoprotein in Caco-2 Cells"],"prefix":"10.1007","volume":"25","author":[{"given":"Naoki","family":"Nishio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"9495_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","volume":"42","author":"J. H. Lin","year":"2003","unstructured":"J. H. Lin and M. Yamazaki. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin. Pharmacokinet. 42:59\u201398 (2003).","journal-title":"Clin. Pharmacokinet."},{"key":"9495_CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","volume":"104","author":"B. Greiner","year":"1999","unstructured":"B. Greiner, M. Eichelbaum, P. Fritz, H. P. Kreichgauer, O. von Richter, J. Zundler, and H. K. Kroemer. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104:147\u2013153 (1999).","journal-title":"J. Clin. Invest."},{"key":"9495_CR3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0014-5793(98)01663-9","volume":"442","author":"M. Demeule","year":"1999","unstructured":"M. Demeule, J. Jodoin, E. Beaulieu, M. Brossard, and R. Beliveau. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS. Lett. 442:208\u2013214 (1999).","journal-title":"FEBS Lett."},{"key":"9495_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1742-7843.2005.pto960322.x","volume":"96","author":"S. Micuda","year":"2005","unstructured":"S. Micuda, L. Mundlova, J. Mokry, J. Osterreicher, J. Cermanova, D. Cizkova, and J. Martinkova. The effect of mdr1 induction on the pharmacokinetics of rhodamine 123 in rats. Basic Clin. Pharmacol. Toxicol. 96:257\u2013258 (2005).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"9495_CR5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/clpt.1983.81","volume":"33","author":"P. G. Wells","year":"1983","unstructured":"P. G. Wells, J. Feely, G. R. Wilkinson, and A. J. Wood. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing. Clin. Pharmacol. Ther. 33:603\u2013608 (1983).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cpt19772217","volume":"22","author":"J. R. Lawrence","year":"1977","unstructured":"J. R. Lawrence, D. J. Sumner, W. J. Kalk, W. A. Ratcliffe, B. Whiting, K. Gray, and M. Lindsay. Digoxin kinetics in patients with thyroid dysfunction. Clin. Pharmacol. Ther. 22:7\u201313 (1977).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00561063","volume":"12","author":"G. M. Shenfield","year":"1977","unstructured":"G. M. Shenfield, J. Thompson, and D. B. Horn. Plasma and urinary digoxin in thyroid dysfunction. Eur. J. Clin. Pharmacol. 12:437\u2013443 (1977).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"9495_CR8","first-page":"302","volume":"16","author":"J. Bonelli","year":"1978","unstructured":"J. Bonelli, H. Haydl, K. Hruby, and G. Kaik. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function. Int. J. Clin. Pharmacol. Biopharm. 16:302\u2013306 (1978).","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"9495_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-198106040-00003","volume":"6","author":"G. M. Shenfield","year":"1981","unstructured":"G. M. Shenfield. Influence of thyroid dysfunction on drug pharmacokinetics. Clin. Pharmacokinet. 6:275\u2013297 (1981).","journal-title":"Clin. Pharmacokinet."},{"key":"9495_CR10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1124\/dmd.105.004770","volume":"33","author":"N. Nishio","year":"2005","unstructured":"N. Nishio, T. Katsura, K. Ashida, M. Okuda, and K. Inui. Modulation of P-glycoprotein expression in hyperthyroid rat tissues. Drug Metab. Dispos. 33:1584\u20131587 (2005).","journal-title":"Drug Metab. Dispos."},{"key":"9495_CR11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mcp.2002.126706","volume":"72","author":"W. Siegmund","year":"2002","unstructured":"W. Siegmund, S. Altmannsberger, A. Paneitz, U. Hecker, M. Zschiesche, G. Franke, W. Meng, R. Warzok, E. Schroeder, B. Sperker, B. Terhaag, I. Cascorbi, and H. K. Kroemer. Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition. Clin. Pharmacol. Ther. 72:256\u2013264 (2002).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR12","doi-asserted-by":"crossref","first-page":"G617","DOI":"10.1152\/ajpgi.00344.2001","volume":"282","author":"K. Ashida","year":"2002","unstructured":"K. Ashida, T. Katsura, H. Motohashi, H. Saito, and K. Inui. Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G617\u2013623 (2002).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"9495_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/endo-105-1-80","volume":"105","author":"H. H. Samuels","year":"1979","unstructured":"H. H. Samuels, F. Stanley, and J. Casanova. Depletion of l-3,5,3\u2032-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80\u201385 (1979).","journal-title":"Endocrinology"},{"key":"9495_CR14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mcp.2000.107912","volume":"68","author":"S. Masuda","year":"2000","unstructured":"S. Masuda, S. Uemoto, T. Hashida, Y. Inomata, K. Tanaka, and K. Inui. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin. Pharmacol. Ther. 68:98\u2013103 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mcp.2000.109797","volume":"68","author":"K. Westphal","year":"2000","unstructured":"K. Westphal, A. Weinbrenner, M. Zschiesche, G. Franke, M. Knoke, R. Oertel, P. Fritz, O. von Richter, R. Warzok, T. Hachenberg, H. M. Kauffmann, D. Schrenk, B. Terhaag, H. K. Kroemer, and W. Siegmund. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug\/drug interaction. Clin. Pharmacol. Ther. 68:345\u2013355 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","volume":"68","author":"D. Durr","year":"2000","unstructured":"D. Durr, B. Stieger, G. A. Kullak-Ublick, K. M. Rentsch, H. C. Steinert, P. J. Meier, and K. Fattinger. St John\u2019s Wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68:598\u2013604 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"9495_CR17","first-page":"F756","volume":"270","author":"L. Jette","year":"1996","unstructured":"L. Jette, E. Beaulieu, J. M. Leclerc, and R. Beliveau. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am. J. Physiol. 270:F756\u2013765 (1996).","journal-title":"Am. J. Physiol."},{"key":"9495_CR18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endo.133.2.8102093","volume":"133","author":"J. Y. Zhao","year":"1993","unstructured":"J. Y. Zhao, M. Ikeguchi, T. Eckersberg, and M. T. Kuo. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133:521\u2013528 (1993).","journal-title":"Endocrinology"},{"key":"9495_CR19","first-page":"361","volume":"1","author":"K. V. Chin","year":"1990","unstructured":"K. V. Chin, S. S. Chauhan, I. Pastan, and M. M. Gottesman. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ. 1:361\u2013365 (1990).","journal-title":"Cell Growth Differ."},{"key":"9495_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1749-6632.1995.tb24843.x","volume":"758","author":"R. C. Ribeiro","year":"1995","unstructured":"R. C. Ribeiro, J. W. Apriletti, B. L. West, R. L. Wagner, R. J. Fletterick, F. Schaufele, and J. D. Baxter. The molecular biology of thyroid hormone action. Ann. N. Y. Acad. Sci. 758:366\u2013389 (1995).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"9495_CR21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/B:PHAM.0000029285.45101.ee","volume":"21","author":"K. Ashida","year":"2004","unstructured":"K. Ashida, T. Katsura, H. Saito, and K. Inui. Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo. Pharm. Res. 21:969\u2013975 (2004).","journal-title":"Pharm. Res."},{"key":"9495_CR22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/endo.138.3.4981","volume":"138","author":"C. J. Torrance","year":"1997","unstructured":"C. J. Torrance, J. E. Devente, J. P. Jones, and G. L. Dohm. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats. Endocrinology 138:1204\u20131214 (1997).","journal-title":"Endocrinology"},{"key":"9495_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3390233","volume":"339","author":"M. Matosin-Matekalo","year":"1999","unstructured":"M. Matosin-Matekalo, J. E. Mesonero, T. J. Laroche, M. Lacasa, and E. Brot-Laroche. Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5. Biochem. J. 339(Pt 2):233\u2013239 (1999).","journal-title":"Biochem. J."},{"key":"9495_CR24","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/bi0301643","volume":"43","author":"J. Huuskonen","year":"2004","unstructured":"J. Huuskonen, M. Vishnu, C. R. Pullinger, P. E. Fielding, and C. J. Fielding. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 43:1626\u20131632 (2004).","journal-title":"Biochemistry"},{"key":"9495_CR25","first-page":"G775","volume":"265","author":"R. A. Giannella","year":"1993","unstructured":"R. A. Giannella, J. Orlowski, M. L. Jump, and J. B. Lingrel. Na(+)-K(+)-ATPase gene expression in rat intestine and Caco-2 cells: response to thyroid hormone. Am. J. Physiol. 265:G775\u2013782 (1993).","journal-title":"Am. J. Physiol."},{"key":"9495_CR26","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.M203221200","volume":"277","author":"X. Li","year":"2002","unstructured":"X. Li, A. J. Misik, C. V. Rieder, R. J. Solaro, A. Lowen, and L. Fliegel. Thyroid hormone receptor \u03b11 regulates expression of the Na+\/H+ exchanger (NHE1). J. Biol. Chem. 277:28656\u201328662 (2002).","journal-title":"J. Biol. Chem."},{"key":"9495_CR27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00003088-198713060-00001","volume":"13","author":"P. O\u2019Connor","year":"1987","unstructured":"P. O\u2019Connor and J. Feely. Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. Clin. Pharmacokinet. 13:345\u2013364 (1987).","journal-title":"Clin. Pharmacokinet."},{"key":"9495_CR28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2125.1981.tb01315.x","volume":"12","author":"H. R. Ochs","year":"1981","unstructured":"H. R. Ochs, D. J. Greenblatt, H. J. Kaschell, U. Klehr, M. Divoll, and D. R. Abernethy. Diazepam kinetics in patients with renal insufficiency or hyperthyroidism. Br. J. Clin. Pharmacol. 12:829\u2013832 (1981).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"9495_CR29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2133\/dmpk.20.324","volume":"20","author":"M. Jin","year":"2005","unstructured":"M. Jin, T. Shimada, M. Shintani, K. Yokogawa, M. Nomura, and K. Miyamoto. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine. Drug Metab. Pharmacokinet. 20:324\u2013330 (2005).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"9495_CR30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/dmd.32.8.779","volume":"32","author":"T. Mitin","year":"2004","unstructured":"T. Mitin, L. L. von Moltke, M. H. Court, and D. J. Greenblatt. Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor. Drug Metab. Dispos. 32:779\u2013782 (2004).","journal-title":"Drug Metab. Dispos."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-007-9495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-007-9495-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-007-9495-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:43:03Z","timestamp":1559353383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-007-9495-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["9495"],"URL":"https:\/\/doi.org\/10.1007\/s11095-007-9495-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]}}}